Dose optimization of intravenous magnesium sulfate after acute stroke

Stroke

Volumn 29, Issue 5, 1998, Pages 918-923

  Muir, Keith W ^a,b   Lees, Kennedy R ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Clinical trials; Magnesium; Neuroprotection; Randomized controlled trials

Indexed keywords

MAGNESIUM SULFATE;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; NEUROPROTECTION; PRIORITY JOURNAL; STROKE;

EID: 0031970836     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.5.918     Document Type: Article

References (47)

1. Marinov MB, Harbaugh KS, Hoopes PJ, Pikus HJ, Harbaugh RE. Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. J Neurosurg. 1996;85:117-124.
2. Stys PK, Ransom BR, Waxman SG. Effects of polyvalent cations and dihydropyridine calcium channel blockers on recovery of CNS white matter from anoxia. Neurosci Lett. 1990;115:293-299.
3. McDonald JW, Silverstein FS, Johnston MV. Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats. Neurosci Lett. 1990;109:234-238.
4. Izumi Y, Roussel S, Pinard E, Seylaz J. Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab. 1991;11:1025-1030.
5. McIntosh TK, Vink R, Yamakami I, Faden AI. Magnesium protects against neurological deficit after brain injury. Brain Res. 1989;482: 252-260.
6. Chi OZ, Pollak P, Weiss HR. Effects of magnesium sulfate and nifedipine on regional cerebral blood flow during middle cerebral artery ligation in the rat. Arch Int Pharmacodyn Ther. 1990;304:196-205.
7. Iseri LT, French JH. Magnesium: nature's physiologic calcium blocker. Am Heart J. 1984;108:188-193.
8. 2+ and MK-801. Eur J Pharmacol. 1988;156:111-120.
9. Davies J, Watkins JC. Effect of magnesium ions on the responses of spinal neurones to excitatory amino acids and acetylcholine. Brain Res. 1977;130:364-368.
10. Harrison NL, Simmonds MA. Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex. Br J Pharmacol. 1985;84:381-391.
11. Ault B, Evans RH, Francis AA, Oakes DJ, Watkins JC. Selective depression of excitatory amino acid induced depolarizations by magnesium ions in isolated spinal cord preparations. J Physiol (Lond). 1980;307:413-428.
12. Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature. 1984;307:462-465.
13. Ascher P, Nowak L. The role of divalent cations in the N-methyl-D-aspartate responses of mouse central neurones in culture. J Physiol (Lond). 1988;399:247-266.
14. 2+-block site of the NMDA receptor channel. Nature. 1992;358:673-675.
15. Smith DAS, Connick JH, Stone TW. Effect of changing extracellular levels of magnesium on spontaneous activity and glutamate release in the mouse neocortical slice. Br J Pharmacol. 1989;97:475-482.
16. Bartrup JT, Stone TW. Presynaptic actions of adenosine are magnesium-dependent. Neuropharmacology. 1988;27:761-763.
17. Ghribi O, Callebert J, Verrecchia C, Plotkine M, Boulu RG. Blockers of NMDA-operated channels decrease glutamate and aspartate extracellular accumulation in striatum during forebrain ischaemia in rats. Fund Clin Pharmacol. 1995;9:141-146.
18. Kass IS, Cottrell JE, Chambers G. Magnesium and cobalt, not nimodipine, protect neurons against anoxic damage in the rat hippocampal slice. Anesthesiology. 1988;69:710-715.
19. 31P-NMR study of transient ischemia in rat hippocampal slices in vitro. Biochim Biophys Acta. 1993;1158: 257-263.
20. Favaron M, Bernardi P. Tissue-specific modulation of the mitochondrial calcium uniporter by magnesium ions. FEBS Lett. 1985;183:260-264.
21. Muir KW, Lees KR. A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke. Stroke. 1995;26:1183-1188.
22. Wester PO, Asplund K, Eriksson S, Hagg E, Lithner F, Strand T. Infusion of magnesium in patients with acute brain infarction. Acta Neurol Scand. 1984;70:143. Abstract.
23. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-1526.
24. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md Med J. 1965;14.61-65.
25. Rankin J. Cerebral vascular accidents in patients over the age of 60, II: prognosis. Scott Med J. 1957;2:200-215.
26. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-607.
27. 2+ administered up to twenty-four hours following reperfusion prevents ischemic damage of the CA1 neurons in the rat hippocampus. Neuroscience. 1991;44:335-341.
28. Schmid-Elsaesser R, Zausinger S, Hungerhuber E, Baethmann A, Reulen H. Additive neuroprotective effects of magnesium and tirilazad in rats subjected to transient focal cerebral ischemia. J Cereb Blood Flow Metab. 1997;17:S103. Abstract.
29. Follis F, Miller K, Scremin OU, Pett S, Kessler R, Wernly J. NMDA receptor blockade and spinal cord ischemia due to aortic crossclamping in the rat model. Can J Neurol Sci. 1994;21:227-232.
30. ++ protect against irreversible damage during CNS ischemia. Stroke. 1984;15:695-698.
31. Kemp PA, Gardiner SM, Bennett T, Rubin PC. Magnesium sulphate reverses the carotid vasoconstriction caused by endothelin-I, angiotensin II and neuropeptide-Y, but not that caused by N(G)-nitro-L-arginine methyl ester, in conscious rats. Clin Sci. 1993;85:175-181.
32. 2+ in isolated human cerebral arteries. Eur J Pharmacol. 1992;229:83-89.
33. Huang QF, Gebrewold A, Zhang A, Altura BT, Altura BM. Role of excitatory amino acids in regulation of rat pial microvasculature. Am J Physiol. 1994;266:R158-R163.
34. Ram Z, Sadeh M, Shacked I, Sahar A, Hadani M. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke. 1991;22:922-927.
35. Hallak M, Berman RF, Irtenkauf SM, Evans MI, Cotton DB. Peripheral magnesium sulfate enters the brain and increases the threshold for hippocampal seizures in rats. Am J Obstet Gynecol. 1992;167:1605-1610.
36. Sjostrom LG, Wester P. Systemically induced hypermagnesemia increases the bioavailability of magnesium in rat brain. Soc Neurosci. 1994;20:181. Abstract.
37. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet. 1995;345:1455-1463.
38. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995;333:201-205.
39. Thurnau GR, Kemp DB, Jarvis A. Cerebrospinal fluid levels of magnesium in patients with preeclampsia after treatment with intravenous magnesium sulfate: A preliminary report. Am J Obstet Gynecol. 1987; 157:1435-1438.
40. Belfort MA, Saade GR, Moise KJ, Jr. The effect of magnesium sulfate on maternal and fetal blood flow in pregnancy-induced hypertension. Acta Obstet Gynecol Scand. 1993;72:526-530.
41. Belfort MA, Saade GR, Moise KJ, Jr. The effect of magnesium sulfate on maternal retinal blood flow in preeclampsia: a randomized placebo-controlled study. Am J Obstet Gynecol. 1992;167:1548-1553.
42. Woods KL, Fletcher S, Roffe C, Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1992;339:1553-1558.
43. Woods KL, Fletcher S. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1994;343: 816-819.
44. ISIS-4 Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet. 1995;345:669-685.
45. Blair JL, Warner DS, Todd MM. Effects of elevated plasma magnesium versus calcium on cerebral ischemic injury in rats. Stroke. 1989;20: 507-512.
46. Roffe C, Thomas L, Fotheringham A, Davies I. The effect of magnesium on infarct size and oedema after middle cerebral artery occlusion. Cerebrovasc Dis. 1996;6:42. Abstract.
47. Nishio A, Gebrewold A, Altura BT, Altura BM. Comparative effects of magnesium salts on reactivity of arterioles and venules to constrictor agents: an in situ study on microcirculation. J Pharmacol Exp Ther. 1988;246:859-865.